GOOD MANUFACTURING PRACTICES FOR ACTIVE PHARMACEUTIAL INGREDIENTS-API (BULK DRUGS)
GOOD MANUFACTURING PRACTICES FOR METERED-DOSE-INHALERS (MDI)
GOOD MANUFACTURING PRACTICES FOR TOPICAL PRODUCTS i.e. EXTERNAL PREPARATIONS (CREAMS, OINTMENTS, PASTES, MULSIONS, LOTIONS, SOLUTIONS, DUSTING POWDERS AND IDENTICAL PRODUCTS)
GOOD MANUFACTURING PRACTICES FOR ORAL LIQUIDS (SYRUPS, ELIXIRS, EMULSIONS AND SUSPENSIONS)
GOOD MANUFACTURING PRACTICES FOR STERILE PRODUCTS, PARENTERAL PREPARATIONS (SMALL VOLUME INJECTABLES AND LARGE VOLUME PARENTERALS) AND STERILE OPHTHALMIC PREPARATIONS.
Corrective and preventative action (CAPA) in pharma refers to the process of identifying, investigating, and addressing any issues or deviations that may have occurred during the production of pharmaceutical products.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an organization that develops guidelines and standards to ensure the global harmonization of the development, registration, and post-approval phases of pharmaceutical products. ICH brings together regulatory authorities and the pharmaceutical industry to create consensus on various aspects of drug development.